Lung Neoplasms: all 7,334 studies
Page 46 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- EBUS-TBNA-RTE VS Radiography in Staging of NSCLCStatus unknownNCT03392506Not applicable
- Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerActive, not recruitingNCT03391869Phase 3
- A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer PatientsActive, not recruitingNCT03390686Phase 3
- Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other DiseasesCompletedNCT03389399
- Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung CancerStatus unknownNCT03389087Phase 2
- APG-1252 in Patients With SCLC or Advanced Solid TumorsTerminatedNCT03387332Phase 1
- BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung CancerCompletedNCT03386955Phase 1/2
- Symptom Collection of Lung Cancer PatientsStatus unknownNCT03384680
- Maekmoondong-tang on Post-operative Cough in Patients With Lung CancerStatus unknownNCT03384667Phase 2/3
- Observational Study for Lung Cancer Patients Treated With NivolumabCompletedNCT03382496
- A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung CancerCompletedNCT03380871Phase 1
- Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLCStatus unknownNCT03379441Phase 2
- The Impacts of Intermittent Chest Tube Clamping on Chest Tube Drainage Duration and Postoperative Hospital Stay After Lung Cancer SurgeryCompletedNCT03379350Not applicable
- Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung BiopsyCompletedNCT03376971Not applicable
- Apatinib in Advanced Non-squamous，NSCLCStatus unknownNCT03376191
- A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC PatientsStatus unknownNCT03373955
- Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC PatientsStatus unknownNCT03372694Phase 3
- Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLCStatus unknownNCT03371992Early Phase 1
- Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung CancerCompletedNCT03371979Phase 1/2
- A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly ChemotherapyCompletedNCT03371550Phase 2
- CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung CancerWithdrawnNCT03370159Phase 1/2
- Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective RegistryStatus unknownNCT03368820
- AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3]TerminatedNCT03366675Phase 2
- Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT03366064Phase 1
- Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal MetastasisStatus unknownNCT03363685
- Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759CompletedNCT03360929Phase 1/2
- Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary FunctionStatus unknownNCT03357094
- Intervention of Engineered Immune Effector T Cells Against Lung CancerWithdrawnNCT03353428Phase 1/2
- Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC PatientsCompletedNCT03351361Phase 3
- Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung CancerStatus unknownNCT03349203Phase 2
- Retrospective Multi-Center Study to Compare Perioperative Outcomes for Robotic-assisted Lobectomy With Those Associated With VATS and Open Lobectomy for Lung CancerCompletedNCT03347825
- Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung CancerStatus unknownNCT03346811Phase 2
- Photodynamic Therapy for the Prevention of Lung CancerWithdrawnNCT03346304Phase 2/3
- Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)CompletedNCT03345810Phase 2
- Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1)CompletedNCT03341377
- Automated Device for Asthma Monitoring and Management in Monitoring Adults With Lung Cancer Undergoing Radiation TherapyCompletedNCT03340714
- Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung CancerWithdrawnNCT03334487Phase 3
- Exercise Intervention During Chemotherapy in Advanced Lung Cancer PatientsStatus unknownNCT03334071Not applicable
- Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung CancerCompletedNCT03331588Phase 3
- A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCompletedNCT03329950Phase 1
- Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine TumoursTerminatedNCT03328065
- Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLCCompletedNCT03326752Phase 1
- Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility TrialCompletedNCT03325907Not applicable
- Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory GatingActive, not recruitingNCT03322072Not applicable
- SABR for T1-2a N1 NSCLCWithdrawnNCT03321760Phase 2
- Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the LungTerminatedNCT03321747Phase 1
- Early Diagnosis of Small Pulmonary Nodules by Multi-omics SequencingCompletedNCT03320044
- Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)WithdrawnNCT03319316Phase 2
- Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung CancerStatus unknownNCT03317080
- 19F Thoracic Radiotherapy for Lung CancerCompletedNCT03315065Early Phase 1
- T-Cell PET Imaging With [18F]F-AraG in Lung CancerWithdrawnNCT03311672Phase 2
- Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted TherapyCompletedNCT03309462Not applicable
- Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour GrowthCompletedNCT03305380
- Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)CompletedNCT03305133
- Immunotherapy by Nivolumab for HIV+ PatientsCompletedNCT03304093Phase 2
- Multiplex Analysis of Circulating Tumor DNAStatus unknownNCT03301961
- Genomic Testing and Resulting Medical DecisionsCompletedNCT03301493
- Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung CancerActive, not recruitingNCT03299478
- Quantification of microRNAs in Diagnosis of Pulmonary NodulesCompletedNCT03293433
- Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor TherapyCompletedNCT03290677Not applicable
- Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)Status unknownNCT03288870Phase 2/3
- Clinical and Molecular Staging of Lung Cancer Stages I and IIpStatus unknownNCT03286036
- Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 AntibodyStatus unknownNCT03282435Phase 1
- Inpatient Smokers and LDCT Screening RCTCompletedNCT03276806Not applicable
- Prognostic Factors on Malignant Pleural EffusionCompletedNCT03276715
- Lung Cancer Registry for Lung Cancer PatientsCompletedNCT03276429
- NanoSpectrometer Biomarker Discovery and Confirmation StudyTerminatedNCT03275688
- Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint InhibitionTerminatedNCT03275597Phase 1
- Whole Body Electromyostimulation and Nutritional Therapy for Patients With Esophageal and Bronchial CarcinomaStatus unknownNCT03274349Not applicable
- A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in JapanCompletedNCT03273790
- Feasibility Study of the RF Ablation Catheter to Ablate Lung TumorsTerminatedNCT03272971Not applicable
- Rational Approach to a Unilateral Pleural EffusionTerminatedNCT03272087Not applicable
- Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in KoreaCompletedNCT03271554
- Olympus - 19-gauge NeedleCompletedNCT03270670
- Comprehensive Care Program SBRTTerminatedNCT03267368Not applicable
- the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)Status unknownNCT03264794Phase 4
- Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung CancerStatus unknownNCT03262948Phase 3
- A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung CancerCompletedNCT03258788
- IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung CancerStatus unknownNCT03258671Not applicable
- A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain MetastasesStatus unknownNCT03257735
- Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMSStatus unknownNCT03257124Phase 2
- Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLCTerminatedNCT03256721Phase 2
- Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung CancerStatus unknownNCT03253068Phase 2
- Breath Analysis to Diagnose Lung CancerCompletedNCT03250390Not applicable
- Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT03245177Phase 1
- Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC PatientsStatus unknownNCT03244605Phase 3
- Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable DiseaseStatus unknownNCT03240549Phase 2
- Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT03240393Phase 2
- Bioinformation Therapy for Lung CancerCompletedNCT03239171Phase 2/3
- Cancer Panel From Blood of Lung Cancer PatientsStatus unknownNCT03235765
- The Effectiveness of Using Preventive Multimedia Teaching Program in Lung Cancer Women Receiving Targeted Therapy on Skin-Related Quality of LifeStatus unknownNCT03231111Not applicable
- Study in Patients With SCLC of Veliparib in Combination With TopotecanStatus unknownNCT03227016Phase 1
- Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally AdvancedActive, not recruitingNCT03225664Phase 1/2
- UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.CompletedNCT03224871Early Phase 1
- Respiratory Distress Symptom Intervention (RDSI) TrialCompletedNCT03223805Not applicable
- Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.Active, not recruitingNCT03220477Phase 1
- Study of Stepped Palliative Care in Patients With Advanced Lung Cancer DF/HCC SOCIAL-BEHAVIORAL RESERACH PROTOCOLTerminatedNCT03220100Not applicable
- Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLCStatus unknownNCT03219762Phase 2
- A Study of MGD013 in Patients With Unresectable or Metastatic NeoplasmsCompletedNCT03219268Phase 1
- Home Respiratory Rehabilitation in Advanced Lung Cancer Chemotherapy Per osTerminatedNCT03216863Not applicable